Study Says Meridia May Up Risk Of Heart Attack, Stroke

Law360, New York (September 2, 2010, 11:15 AM EDT) -- A study published Thursday in The New England Journal of Medicine warned that Abbott Laboratories’ weight-loss drug Meridia may increase the risk of nonfatal heart attack and stroke in some users, raising new concerns about the controversial pill just weeks before a U.S. advisory panel is set to consider its fate.

The Abbott-funded study found that Meridia — the brand name for sibutramine hydrochloride — could increase the chances of nonfatal heart attacks and strokes in obese users over the age of 55 years with preexisting...
To view the full article, register now.